Exane BNP Paribas initiated coverage of Healthpeak with an Underperform rating and $18 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PEAK: